Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Long-Term Investments (2020)

Intelligent Bio Solutions has reported Long-Term Investments over the past 1 years, most recently at $135692.0 for Q2 2020.

For Q2 2020, Long-Term Investments changed N/A year-over-year to $135692.0; the TTM value through Jun 2020 reached $135692.0, changed N/A, while the annual FY2020 figure was $135692.0, N/A changed from the prior year.
Long-Term Investments for Q2 2020 was $135692.0 at Intelligent Bio Solutions.
Over five years, Long-Term Investments peaked at $135692.0 in Q2 2020 and troughed at $135692.0 in Q2 2020.